Literature DB >> 349853

Oral administration of neomycin to chickens experimentally infected with Salmonella typhimurium.

H W Smith, J F Tucker.   

Abstract

Groups of healthy chickens with a light experimental Salmonella typhimurium infection were fed on a diet containing 225 g per ton (1016 kg) of neomycin for two days. This brought about only a slight reduction in the incidence of chickens that were excreting S typhimurium in their faeces. Examination of caecal contents two days after the cessation of treatment revealed the neomycin had not had any effect in eliminating infection. In one experiment, the neomycin administration resulted in the emergence of enormous populations of Escherichia coli in the alimentary tract of treated chickens that possessed multiple antibiotic resistance of the transmissible type. For these reasons the practice of feeding broiler chickens on diets containing neomycin immediately before slaughter should be actively discouraged.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 349853     DOI: 10.1136/vr.102.16.354

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

Review 1.  Poultry meat as a source of human salmonellosis in England and Wales. Epidemiological overview.

Authors:  T J Humphrey; G C Mead; B Rowe
Journal:  Epidemiol Infect       Date:  1988-04       Impact factor: 2.451

2.  Drug enrichment of commercial poultry feeds and human health in the tropical developing countries.

Authors:  A A Ojeniyi
Journal:  Acta Vet Scand       Date:  1989       Impact factor: 1.695

Review 3.  Review of antimicrobial therapy of selected bacterial diseases in broiler chickens in Canada.

Authors:  Agnes Agunos; Dave Léger; Carolee Carson
Journal:  Can Vet J       Date:  2012-12       Impact factor: 1.008

4.  Public health aspects of bacterial drug resistance in modern battery and town/village poultry in the tropics.

Authors:  A A Ojeniyi
Journal:  Acta Vet Scand       Date:  1989       Impact factor: 1.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.